The size of the Asia Pacific Hybrid MRI Systems Market is forecasted to be growing at a healthy rate during the forecast period.
Magnetic resonance imaging (MRI) is a method that uses radio waves and a magnetic field to create detailed images of the organs and tissues present in your body. MRI systems combined with other techniques give us hybrid MRI. X-ray/MRI Systems facilitate minimum invasive procedure by providing information about anatomy and physiology. MRI combined with MPI gives the possibility of acquiring superficially high-quality pictures of tissues or organs inside the body. MRI Combined with PET gives complete insight in to human body without any limitations in any branch of science. MRI/PET is also used for better diagnosis of Breast Cancer. MRI Systems combined with Radiography is used to treat infertility patients.
Increase in aging population, Developing Markets, and development of MRI compatible pacemakers, developments in MRI techniques, open architecture, and software Application are some of the factors driving the market. However, factors like draining helium gas deposits, high cost of MRI systems, lack of skilled labour, declining reimbursement rates, and complexity of machines are restraining the market. This is the fastest growing region in the world because of developing market and increase in spending limits of people.
This research report on the Asia Pacific Hybrid MRI Systems Market has been segmented and sub-segmented into the following categories.
By Field Strength:
By Type:
By Application:
By Country:
Some of the key companies dominating the Asia pacific Hybrid MRI Systems Market profiled in the report are Hitachi Medical Corporation (Japan), Toshiba Medical Systems (Japan), Siemens Healthcare (Germany), GE Healthcare (U.K.), and Philips Healthcare (Netherlands).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Field Strength
5.1.1 Introduction
5.1.2 Low to mid Field
5.1.3 High Field
5.1.4 Very High Field
5.1.5 Ultra High Field
5.1.6 Y-o-Y Growth Analysis, By Field Strength
5.1.7 Market Attractiveness Analysis, By Field Strength
5.1.8 Market Share Analysis, By Field Strength
5.2 Type
5.2.1 Introduction
5.2.2 X-Ray/MRI
5.2.3 PET/MRI
5.2.4 Radiography/MRI
5.2.5 MPI/MRI
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Brain
5.3.3 Pelvic
5.3.4 Cardiac
5.3.5 Abdominal
5.3.6 Musculoskeletal
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Field Strength
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Field Strength
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Field Strength
6.1.5.3 By Type
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Hitachi Medical Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Toshiba Medical Systems
8.3 Siemens Healthcare
8.4 GE Healthcare
8.5 Philips Healthcare
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
